PUBLISHER: SkyQuest Technology Consulting Pvt. Ltd. | PRODUCT CODE: 1213655
PUBLISHER: SkyQuest Technology Consulting Pvt. Ltd. | PRODUCT CODE: 1213655
Global Lipids in Human Nutrition Market was valued at USD 13.3 Billion in 2021, and it is expected to reach a value of USD 19.2 Billion by 2028, at a CAGR of 5.9% over the forecast period (2022-2028).
Global market growth for the product has accelerated due to rising consumption in the creation of COVID-19 vaccines. By the end of 2023, Partners in Health estimated that the world would need over 22 million additional vaccines to stabilize COVID-19's impacts and bring them under control.
Over the projection period, this is anticipated to boost the global demand for lipids for human nutrition.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global lipids in human nutrition market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Segments covered in this report:
The Global Lipids in Human Nutrition Market is segmented based on Type, Application, and Region. Based on the Type, the Market are segmented as Triglycerides, Phospholipids, and Others. Based on the Application, the Market is segmented as Dietary Supplements, Functional Nutrition, Sports Nutrition, and Infant Nutrition. Based on Region it is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.
Driver
Because of their high concentration of nutrients including energy and fat-soluble vitamins, lipids are regarded as a crucial component in the creation of dietary supplements. COVID-19 and people's growing health concerns have fueled dietary supplement demand all around the world. Additionally, the availability of nutritional supplements in a number of shapes and flavors has increased their social acceptability among individuals of all ages. Over the anticipated years, rising dietary supplement intake is anticipated to increase the demand for lipids for human nutrition.
Restraint
The Lipids market is constrained by ongoing R&D expenses, expenditures in labs and research apparatus, and the high cost of hiring qualified personnel. The market has expanded as a result of the government regulations governing the use of lipids in various applications. Since lipid applications are associated with health advantages, businesses can have trouble recovering their initial investment.
Market Trends
Lipids have a significant impact on the creation of COVID-19 mRNA-based vaccines. Manufacturers have been forced to increase their lipid manufacturing due to the enormous demand for it in the creation of COVID-19 vaccinations for the entire world population. Merck KGaA stated that they have been putting in a lot of effort to increase their lipid production capacity in February 2021. Evonik Industries also announced its intention to increase production at two of its German plants in February 2021. This has helped the market expansion during the last two years, among other things.